Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Dysphagia
Published in: Dysphagia 6/2022

Open Access 16-02-2022 | Cough | Original Article

Expiratory Muscle Strength Training for Drooling in Adults with Parkinson’s Disease

Authors: Naomi Cocks, Jonathan Rafols, Elizabeth Embley, Kylie Hill

Published in: Dysphagia | Issue 6/2022

Login to get access

Abstract

One of the most debilitating symptoms of advanced Parkinson’s disease is drooling. Currently, the main treatment that is offered for drooling is botulinum toxin injections to the saliva glands which have a number of side effects and do not treat the causes of drooling, such as impaired swallowing and lip closure. This study explored the effect of an alternative therapy approach for drooling that aimed at improving the swallow, expiratory muscle strength training (EMST). Sixteen participants received EMST over a 6- to 8-week period. Measurements were taken pre- and post-training for drooling (Sialorrhea Clinical Scale for Parkinson’s Disease; SCS-PD), swallowing, lip strength and peak cough flow. Measures of drooling, swallowing and peak cough flow were stable over pre-training assessments and improved following training (p < 0.01). The most conservative estimate of the within-group change for SCS-PD was − 2.50 (95% confidence interval −  3.22 to −  1.22). No adverse effects were reported and participants gave high satisfaction ratings for the training. A programme of EMST offers promise as a therapy to reduce drooling for people with Parkinson’s disease. Adequately powered randomised controlled trials of EMST are now needed.
Literature
1.
Kalf JG, de Swart BJ, Borm GF, Bloem BR, Munneke M. Prevalence and definition of drooling in Parkinson’s disease: a systematic review. J Neurol. 2009;256:1391–6.CrossRefPubMedPubMedCentral
2.
Bagheri H, Damase-Michel C, Lapeyre-Mestre M, Cismondo S, O’Connell D, Senard JM, Rascol O, Montastruc JL. A study of salivary secretion in Parkinson’s disease. Clin Neuropharmacol. 1999;22:213–5.PubMed
3.
Kalf JG, Munneke M, van den Engel-Hoek L, de Swart BJ, Borm GF, Bloem BR, Zwarts MJ. Pathophysiology of diurnal drooling in Parkinson’s disease. Mov Disord. 2011;26:1670–6.CrossRefPubMed
4.
Politis M, Wu K, Molloy S, Bain PG, Chaudhuri RK, Piccini P. Parkinson’s disease symptoms: the patient’s perspective. Mov Disord. 2010;25:1646–51.CrossRefPubMed
5.
Pitts T, Bolser D, Rosenbek J, Troche M, Sapienza C. Voluntary cough production and swallow dysfunction in Parkinson’s disease. Dysphagia. 2008;23:297–301.CrossRefPubMedPubMedCentral
6.
Hely MA, Morris JGL, Traficante R, Reid WGJ, O’Sullivan DJ, Williamson PM. The ydney multicentre study of Parkinson’s disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry. 1999;67:300–7.CrossRefPubMedPubMedCentral
7.
8.
Bhatia KP, Münchau A, Brown P. Botulinum toxin is a useful treatment in excessive drooling of saliva. J Neurol Neurosurg Psychiatry. 1999;67:697–697.CrossRefPubMedPubMedCentral
9.
Contarino MF, Pompili M, Tittoto P, Vanacore N, Sabatelli M, Cedrone A, Rapaccini GL, Gasbarrini G, Tonali PA, Bentivoglio AR. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson’s disease. Parkinsonism Relat Disord. 2007;13:299–303.CrossRefPubMed
10.
Ondo WG, Hunter C, Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease. Neurology. 2004;62:37–40.CrossRefPubMed
11.
Tan EK, Lo YL, Seah A, Auchus AP. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. J Neurol Sci. 2001;190:95–7.CrossRefPubMed
12.
Nicolau PJ. The orbicularis oris muscle: a functional approach to its repair in the cleft lip. Br J Plast Surg. 1983;36:141–53.CrossRefPubMed
13.
Oh D-H, Park J-S, Kim W-J. Effect of neuromuscular electrical stimulation on lip strength and closure function in patients with dysphagia after stroke. J Phys Ther Sci. 2017;29:1974–5.CrossRefPubMedPubMedCentral
14.
Park H-S, Park J-Y, Kwon Y-H, Choi HS, Kim HJ. Effect of orbicularis oris muscle training on muscle strength and lip closure function in patients with stroke and swallowing disorder. J Phys Ther Sci. 2018;30:1355–6.CrossRefPubMedPubMedCentral
15.
Yanagisawa Y, Matsuo Y, Shuntoh H, Horiuchi N. Effect of expiratory resistive loading in expiratory muscle strength training on orbicularis oris muscle activity. J Phys Ther Sci. 2014;26:259–61.CrossRefPubMedPubMedCentral
16.
Pitts T, Bolser D, Rosenbek J, Troche M, Okun MS, Sapienza C. Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest. 2009;135:1301–8.CrossRefPubMedPubMedCentral
17.
Troche MS, Okun MS, Rosenbek JC, Musson N, Fernandez HH, Rodriguez R, Romrell J, Pitts T, Wheeler-Hegland KM, Sapienza CM. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial(LOE Classification). Neurology. 2010;75:1912–9.CrossRefPubMedPubMedCentral
18.
Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51:745–52.CrossRefPubMedPubMedCentral
19.
Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRefPubMed
20.
Wooten G, Currie L, Bovbjerg V, Lee JY, Patrie J. Are men at greater risk for Parkinson’s disease than women? J Neurol Neurosurg Psychiatry. 2004;75:637–9.CrossRefPubMedPubMedCentral
21.
Perez Lloret S, Piran Arce G, Rossi M, CaivanoNemet ML, Salsamendi P, Merello M. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson’s disease. Mov Disord. 2007;22:107–11.CrossRefPubMed
22.
Mann G. MASA: the Mann assessment of swallowing ability. Singular: Thomson Learning, Inc; 2002.
23.
McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell KA, Kramer AE, Earl Bricker D. The SWAL–QOL and SWAL–CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17:97–114.CrossRefPubMed
24.
Crary MA, Mann GDC, Groher ME. Initial psychometric assessment of a Functional Oral Intake Scale for dysphagia in stroke Patients. Arch Phys Med Rehabil. 2005;86:1516–20.CrossRefPubMed
25.
Mann G, Hankey GJ, Cameron D. Swallowing disorders following acute stroke: prevalence and diagnostic accuracy. Cerebrovasc Dis. 2000;10:380–6.CrossRefPubMed
26.
McHorney CA, Bricker DE, Robbins J, Kramer AE, Rosenbek JC, Chignell KA. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling. Dysphagia. 2000;15:122–33.CrossRefPubMed
27.
Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43:1334–59.CrossRefPubMed
28.
Hill K, Jenkins SC, Philippe DL, Cecins N, Shepherd KL, Green DJ, Hillman DR, Eastwood PR. High-intensity inspiratory muscle training in COPD. Eur Respir J. 2006;27:1119–28.CrossRefPubMed
29.
30.
Marshall J, Best W, Cocks N, Cruice M, Pring T, Bulcock G, Creek G, Eales N, Mummery AL, Matthews N, Caute A. Gesture and naming therapy for people with severe aphasia: a group study. J Speech Lang Hear Res. 2012;55:726–38.CrossRefPubMed
31.
Palermo S, Lopiano L, Zibetti M, Rosato R, Leotta D, Amanzio M. A novel framework for understanding reduced awareness of dyskinesias in Parkinson’s disease. Parkinsonism Relat Disord. 2017;39:58–63.CrossRefPubMed
32.
Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K, Yang C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Dysautonomia rating scales in Parkinson’s disease: Sialorrhea, dysphagia, and constipation—critique and recommendations by movement disorders task force on rating scales for Parkinson’s disease. Mov Disord. 2009;24:635–46.CrossRefPubMedPubMedCentral
Metadata
Title
Expiratory Muscle Strength Training for Drooling in Adults with Parkinson’s Disease
Authors
Naomi Cocks
Jonathan Rafols
Elizabeth Embley
Kylie Hill
Publication date
16-02-2022
Publisher
Springer US
Published in
Dysphagia / Issue 6/2022
Print ISSN: 0179-051X
Electronic ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-022-10408-6

Other articles of this Issue 6/2022

Dysphagia 6/2022 Go to the issue

Original Article

Factors Associated with Food Form in Long-Term Care Insurance Facilities

Original Article

Using an Automated Speech Recognition Approach to Differentiate Between Normal and Aspirating Swallowing Sounds Recorded from Digital Cervical Auscultation in Children

Original Article

Statistical Power and Swallowing Rehabilitation Research: Current Landscape and Next Steps

Original Article

Accuracy of High-Resolution Pharyngeal Manometry Metrics for Predicting Aspiration and Residue in Oropharyngeal Dysphagia Patients with Poor Pharyngeal Contractility

Original Article

Dysphagia in Intensive Care Evaluation (DICE): An International Cross-Sectional Survey

Original Article

A Novel Balloon Catheter-based Dilation Intervention for Patients with Cricopharyngeus Achalasia After Stroke: A Randomized Study